USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA
Authors:
Hong-Yan Zhang aff001; Bo-Wei Liao aff001; Zhi-Sheng Xu aff001; Yong Ran aff001; Dong-Peng Wang aff001; Yan Yang aff001; Wei-Wei Luo aff001; Yan-Yi Wang aff001
Authors place of work:
Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China
aff001; University of Chinese Academy of Sciences, Beijing, China
aff002
Published in the journal:
USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA. PLoS Pathog 16(1): e32767. doi:10.1371/journal.ppat.1008178
Category:
Research Article
doi:
https://doi.org/10.1371/journal.ppat.1008178
Summary
Mediator of IRF3 activation (MITA, also known as stimulator of interferon genes, STING) senses the second messenger cyclic GMP-AMP (cGAMP) which is synthesized upon DNA virus infection and activates innate antiviral immune response. It has been demonstrated that the activity of MITA is delicately regulated by various post-translational modifications including polyubiquitination. In this study, we identified the deubiquitinating enzyme USP44 as a positive regulator of MITA. USP44 is recruited to MITA following DNA virus infection and removes K48-linked polyubiquitin moieties from MITA at K236, therefore prevents MITA from proteasome mediated degradation. USP44-deficiency results in acceleration of HSV-1-induced degradation of MITA and reduced induction of type I interferons (IFNs) and proinflammatory cytokines. Consistently, Usp44-/- mice are more susceptible to HSV-1 infection as indicated by higher tissue viral titers, greater tissue damage and lower survival rate. These findings suggest that USP44 plays a specific and critical role in the regulation of innate immune response against DNA viruses.
Keywords:
Immune response – DNA viruses – DNA transcription – Plasmid construction – Interferons – Immunoblotting – Enzyme regulation – Vector-borne diseases
Introduction
The innate immune response is the first line of host defense against pathogens. Germline-encoded pattern recognition receptors (PRRs) recognize conserved molecular motifs of pathogens called pathogen-associated molecular patterns (PAMPs) and trigger a series of signaling events, leading to induction of type I IFNs, proinflammatory cytokines and downstream antiviral effector proteins, which eventually inhibit the replication of pathogens and eliminate the infected cells [1–4].
Viral nucleic acids act as typical PAMPs that trigger innate immune response. Viral RNAs are recognized by endosomal Toll-like receptors (TLRs) and cytosolic RIG-I-like receptors (RLRs) such as retinoic acid-inducible gene-1 (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) [5–7]. Meanwhile, several proteins have been identified as viral DNA sensors, including Toll-like receptor 9 (TLR9), DNA-dependent activator of IFN-regulatory factors (DAI), RNA polymerase III (Pol-III), IFN-γ-inducible protein 16 (IFI16), DEAD-box helicase 41 (DDX41) and LSM14A [8–13]. However, evidence suggest that these proteins are not universally needed for recognizing viral DNA in various cell types or in vivo [14]. In recent years, the nucleotidyltransferase family protein cyclic GMP-AMP (cGAMP) synthase (cGAS) is identified as a cytosolic DNA sensor that induces interferons irrespective of cell type or DNA sequence [15–17]. Upon sensing viral dsDNA, cGAS catalyzes synthesis of cGAMP [16]. cGAMP then binds to and activates adaptor protein MITA (also known as endoplasmic reticulum (ERIS), MPYS and STING), which is located on the endoplasmic reticulum (ER) membrane [18–23]. Once associated with cGAMP, MITA traffics from ER through Golgi apparatus to perinuclear microsomal compartments [19, 24, 25]. During this process, MITA recruits the TANK-binding kinase 1 (TBK1) and is phosphorylated by TBK1, which is important for MITA to recruit interferon regulatory factor 3 (IRF3) [18, 24]. IRF3 undergoes phosphorylation by TBK1. Phosphorylated IRF3 form dimers and translocate to the nucleus, leading to the induction of type I IFNs and downstream effector genes [26, 27].
As a key adaptor protein in innate immune response against DNA viruses, the activity of MITA is delicately regulated. Several post-translational modifications, such as phosphorylation, sumoylation and polyubiquitination, have been reported to play important roles in regulation of MITA [28]. For example, phosphorylation of MITA at Ser358 and Ser366 is crucial for its activation and recruitment of IRF3 [18, 26, 27]; sumoylation of MITA in the early phase of viral infection by TRIM38 promotes its stability and activation whereas desumoylation of MITA in the late phase by SENP2 leads to its degradation thus avoiding sustained activation of MITA [29]. In addition, polyubiquitination of MITA have also been reported to distinctly regulate its activity. The E3 ubiquitin ligases TRIM56 and TRIM32 mediated K63-linked polyubiquitination of MITA and AMFR mediated K27-linked polyubiquitination of MITA have been shown to enhance the antiviral innate immune response [30–32]. RNF5 catalyzes K48-linked polyubiquitination of MITA that results in its degradation [33], and this could be inhibited by RNF26 mediated K11-linked polyubiquitination of MITA at the same site [34].
Deubiquitination is a reverse biochemical process of polyubiquitination, in which polyubiquitin chains previously added to target proteins are removed by deubiquitinating enzymes (DUBs). Recently, several DUBs have been reported to regulate the antiviral innate immune response. For example, USP14 removes K48-linked polyubiquitination of cGAS therefore impairs autophagic degradation of cGAS [35]. It has been reported that USP13 removes K27-linked polyubiquitin chains from MITA and inhibits interaction between MITA and TBK1, resulting in impaired antiviral innate immune response [36]. USP49 has been shown to deconjugate K63-linked polyubiquitin chains from MITA and inhibits the aggregation and activation of MITA [37].
In this study, we screened for DUBs that involve in DNA virus-triggered induction of type I IFNs and identified ubiquitin-specific protease 44 (USP44) as a positive regulator. USP44 consists of 712 amino acids, which contains a Zn-finger domain at the N-terminus and a USP domain at the C-terminus [38]. USP44 has been shown to be involved in many cellular processes, including embryonic stem cell (ESC) differentiation, cell proliferation, DNA repair and tumor progression [39–43]. However, it is dispensable for the differentiation of hematopoietic stem cells (HSC) and barely affects the development of immune cells [44]. So far, whether USP44 is involved in immune response is unclear. We found that overexpression of USP44 potentiated DNA- but not RNA virus-triggered production of type I IFNs and proinflammatory cytokines. Conversely, USP44 deficiency suppressed cytosolic DNA- and DNA virus-triggered innate immune response. Further study revealed that USP44 was recruited to MITA and selectively removed K48-linked polyubiquitin chains from MITA at K236, therefore inhibited proteasome-mediated degradation of MITA and promoted antiviral response against DNA viruses. Our study shed new light on the function of USP44 and further demonstrated the importance of deubiquitination in the regulation of antiviral innate immune response.
Results
USP44 positively regulates DNA virus-induced innate immune response
To identify potential molecules involved in DNA-triggered signaling. We screened ~40 independent human DUB cDNA expression plasmids for their abilities to regulate the IFNB promoter in reporter assays. These efforts led to identification of USP44 as a candidate protein that could potentiate activation of the IFNB promoter triggered by the DNA virus herpes simplex virus 1 (HSV-1) (S1 Fig). Overexpression of USP44 potentiated HSV-1-, but not SeV-induced activation of the IFNB promoter, interferon-stimulated response element (ISRE) and NF-κB in a dose-dependent manner in HEK293 cells (Fig 1A). Consistently, overexpression of USP44 enhanced cGAS-MITA-induced activation of the IFNB promoter in a dose-dependent manner (Fig 1B). We next established a THP-1 cell line stably expressing USP44. qPCR experiments indicated that USP44 enhanced transcription of IFNB1, IFIT1, IL6 and CXCL10 genes in response to HSV-1 (Fig 1C). In addition, transcription of downstream genes induced by transfected HSV120 (120-mer dsDNA representing the genome of HSV-1) was also enhanced in USP44-expressing THP-1 cells (Fig 1D). In contrast, the transcription of downstream genes induced by SeV was not markedly affected in USP44-expressing THP-1 cells (Fig 1E). Moreover, USP44 enhanced HSV-1-induced phosphorylation of TBK1, IRF3, IKKβ and p65 (Fig 1F). These results suggest that USP44 specifically regulates in DNA virus-triggered innate immune response.
Knockdown of USP44 inhibits DNA virus-triggered signaling
To confirm the role of endogenous USP44 in DNA virus-triggered signaling, we designed two pSuper-RNAi constructs which could efficiently knockdown the expression of USP44 (Fig 2A). qPCR experiments indicated that transcription of IFNB1, IL6 and CXCL10 induced by HSV-1 infection and transfected dsDNA, such as HSV120 and interferon stimulating DNA (ISD), was markedly reduced in USP44-RNAi expressing THP-1 cells compared with control cells (Fig 2B and S2 Fig). In contrast, knockdown of USP44 had little effects on SeV-induced the transcription of downstream genes in THP-1 cells (Fig 2C). Knockdown of USP44 also reduced HSV-1-induced phosphorylation of TBK1, IRF3, IKKβ and p65 in THP-1 cells (Fig 2D).
To determine whether USP44 regulates in a cell- and virus-specific manner, we used independent siRNA construct to knockdown USP44 in human foreskin fibroblasts (HFFs), which are permissive to human cytomegalovirus (HCMV) infection. We found that knockdown of USP44 inhibited HCMV- and HSV120-induced transcription of IFNB1, IFIT1, IL6 and CXCL10 genes (Fig 2E), but had no marked effects on SeV- or dsRNA mimic poly(I:C)-induced transcription of antiviral genes in HFFs (Fig 2F). These results suggest that USP44 plays a general role in modulating innate immune response to DNA virus in various cell types.
USP44-deficiency impairs innate immune response to DNA viruses in mice
To further investigate the roles of USP44 in vivo, we used Usp44 knockout mice (S3A Fig). Usp44 mRNA was lowly expressed in wild-type bone marrow-derived macrophages (BMDMs) and murine lung fibroblasts (MLFs), but was up-regulated following HSV-1 infection. In these cells, Usp44 mRNA was not detectable either before or after HSV-1 infection in Usp44-/- cells (S3B Fig). qPCR experiments indicated that transcription of Ifnb1, Ifit1, Il6 and Cxcl10 genes induced by HSV-1 and Vaccinia virus (VACV) infection was significantly dampened in Usp44-/- compared with Usp44+/+ BMDMs (Fig 3A and S3C Fig). In addition, transcription of downstream genes induced by transfected HSV120 and ISD was also inhibited in BMDMs (Fig 3B and S3D Fig). In contrast, USP44-deficiency showed no effects on the transcription of antiviral genes induced by SeV or transfected poly(I:C) (Fig 3C and 3D). Consistently, HSV-1-induced phosphorylation of TBK1, IRF3, IKKβ and p65, but not SeV-induced phosphorylation of TBK1, was dramatically impaired in Usp44-/- BMDMs (Fig 3E). Similar results were also found in Usp44-/- mouse lung fibroblasts (MLFs) (S3E–S3G Fig).
To investigate whether USP44 is important for host antiviral response in vivo, wild-type and Usp44 knockout mice were intra-peritoneally infected with HSV-1 at lethal or non-lethal dose. While the concentrations of serum cytokines including IFN-β, IL-6 and CXCL10 were obviously lower in Usp44-/- than that in the wild type mice (Fig 4A and 4B), the lung and brain levels of HSV-1 ICP22 and ICP27 mRNA as well as the brain viral titre were significantly increased in Usp44-/- mice (Fig 4C and 4D). Similar results were obtained when mice are intra-nasally infected (Fig 4E). Furthermore, hematoxylin and eosin staining indicated that the lung tissues of Usp44-/- mice exhibited greater infiltration of immune cells and tissue damage after HSV-1 infection compared with that of Usp44+/+ mice (Fig 4F). Consistently, Usp44-/- mice were more susceptible to HSV-1-, but not VSV-induced death compared to their wild-type littermates (Fig 4G and 4H). Collectively, these data suggest that USP44 is essential for host defense against DNA virus infection.
USP44 acts at the level of MITA
To investigate the mechanisms on how USP44 modulates innate immune responses to DNA viruses, we examined the effects of USP44 on activation of the IFNB promoter mediated by components of the DNA-triggered signaling pathways. Reporter assays indicated that co-transfection of USP44 enhanced activation of the IFNB promoter mediated by cGAS and MITA but had no marked effects on activation of the IFNB promoter mediated by their downstream components TBK1 and IRF3-5D (a constitutively active mutant of IRF3) (Fig 5A). Interestingly, knockdown of USP44 in THP-1 cells or knockout of Usp44 in mouse BMDMs inhibited cGAMP-triggered transcription of downstream genes (Fig 5B). These results indicate that USP44 acts downstream of cGAMP and upstream of TBK1-IRF3. Consistently, transient transfection and coimmunoprecipitation experiments showed that USP44 interacted with MITA but not cGAS, TBK1, IKKε or IRF3 (Fig 5C). Unfortunately, after extensive efforts, our study, as well as the published studies on USP44 [39–42, 44] have not been able to identify a USP44 antibody that can detect endogenous USP44 protein. To overcome this obstacle, we reconstituted immortalized Usp44-/- MLF cells (iMLFs) with Flag-tagged USP44 (USP44-Flag) by retrovirus-mediated transduction. Using this cell line, we found that USP44 was associated with MITA after HSV-1 infection (Fig 5D). USP44 have been reported to mainly localize in the nucleus [38, 43]. However, in the subcellular fractionation experiments, USP44 was detected in both the nuclear and cytoplasmic fractions (S4 Fig). Since MITA is a transmembrane protein [19, 21], we further examined whether USP44 was recruited to membranes during HSV-1 infection. As shown in Fig 5E (top panel), while USP44 was detected in both the membraneous and cytosolic fractions in uninfected cells, it migrated from cytosol to membranes after HSV-1 infection (Fig 5E, top panel). Importantly, co-immunoprecipitation experiments with the membraneous fraction demonstrated that USP44 associated with MITA on membranes (Fig 5E, bottom panel). Taken together, these results suggest that USP44 is recruited to membrane-localized MITA after HSV-1 infection.
USP44 deubiquitinates and stabilizes MITA
Since USP44 is a DUB, we determined whether USP44 functions by deubiquitinating MITA. Reporter assays indicated that USP44(C282A), a deubiquitinase inactive mutant of USP44, lost its ability to enhance cGAS-MITA-mediated activation of the IFNB promoter (Fig 6A). qPCR experiments showed that USP44 but not USP44(C282A) promoted transcription of downstream effector genes induced by HSV-1 infection or transfected HSV120 in THP-1 cells (Fig 6B). Consistently, USP44(C282A) also lost its ability to potentiate phosphorylation of TBK1, IRF3, IKKβ and p65 triggered by HSV-1 infection (Fig 6C). To further confirm whether the deubiquitinase activity of USP44 was required for its function, we reconstituted Usp44-/- iMLFs with wild-type USP44 or USP44(C282A) respectively. qPCR results showed that HSV-1-induced transcription of Ifnb1, Il6 and Cxcl10 genes was rescued by reconstitution of USP44 but not USP44(C282A) (Fig 6D). These results suggest that the enzymatic activity of USP44 is essential for its regulation of innate immune response to DNA viruses.
We next determined whether USP44 can deubiquitinate MITA. We found that USP44 but not USP44(C282A) caused deubiquitination of MITA (Fig 7A). In vitro experiments confirmed that USP44 but not USP44(C282A) directly deubiquitinated MITA (Fig 7B). Conversely, USP44-deficiency increased HSV-1-induced polyubiquitination of MITA in BMDMs (Fig 7C).
To further examine which type of polyubiquitin moieties USP44 removes from MITA, we performed deubiquitination assays with wild-type ubiquitin and the K-only mutants of ubiquitin including K11O, K27O, K29O, K33O, K48O and K63O, in which only the indicated lysine residue was retaining. As shown in Fig 7D, USP44 selectively removed K48- but not other linkage-mediated polyubiquitin moieties from MITA (Fig 7D). In addition, deubiquitination assays with ubiquitin mutants K6R, K11R, K27R, K29R, K33R, K48R and K63R, in which only the indicated lysine residue was mutated to arginine, showed that USP44 impaired MITA ubiquitination of all tested linkages but failed to deubiquitinate MITA when the K48 residue of ubiquitin was mutated (Fig 7E), indicating that USP44 specifically removes K48-linked polyubiquitin chains from MITA. To further confirm this conclusion, we examined the level of K48- and K63-linked ubiquitination of endogenous MITA induced by HSV-1 infection in WT and Usp44-/- cells. The results showed that knockout of USP44 potentiated K48- but not K63-linked ubiquitination of endogenous MITA (Fig 7F).
Next we investigated which residue(s) of MITA was targeted by USP44. We performed deubiquitination assays with MITA and a series of its KR mutants where the lysine residues have been individually mutated to arginine. The results showed that among all the KR mutants of MITA, the K236R mutant was resistant to USP44-mediated deubiquitination while the K150R and K224R mutants also exhibited minimal resistance, suggesting that USP44 mainly deubiquitinates MITA at K236 (Fig 7G). Taken together, these findings suggest that USP44 mainly deconjugates K48-linked polyubiquitin chains from MITA at K236.
It has been shown that viral infection-triggered K48-polyubiquitination of MITA promotes its degradation by proteosomes [33, 45–47]. As shown in Fig 7H & 7I, HSV-1 induced degradation of MITA was aggravated in Usp44-/- MLFs compared with the wild-type cells. Importantly, such aggravation was rescued by reconstitution of Usp44-/- MLFs with USP44 but not USP44(C282A), or by proteasomal but not autophagic or lysosomal inhibitors (Fig 7H and 7I). Taken together, these findings indicate that USP44 prevents MITA from undergoing proteasome-mediated degradation by removing K48-linked polyubiquitination chains at K236 of MITA after DNA virus infection.
USP44-mediated regulation of cGAS-MITA signaling is independent of USP20 and CYLD
It has been reported that the deubiquitin enzymes USP20 and CYLD could remove K48-linked polyubiquitin moieties from MITA [48, 49]. Therefore, we further investigated the relevance of USP44, USP20 and CYLD in their regulation of MITA-mediated signaling. As shown in S5A and S5B Fig, USP44 cooperated with USP20 or CYLD to further enhance cGAS-MITA-mediated activation of IFNB promoter, ISRE and NF-κB, as well as to further remove K48-linked polyubiquitin chains from MITA (S5A and S5B Fig). In reconstitution experiments, HSV-1-triggered transcription of Ifnb1, Il6 and Cxcl10 genes was rescued by reconstitution of USP44 but not the enzymatically inactive mutant C282A, USP20, or CYLD in Usp44-/- iMLFs (S5C Fig). These data indicate that USP44-mediated regulation of MITA is independent of USP20 or CYLD.
Discussion
The cGAS-MITA pathway plays an important role in innate immune response to DNA viruses [15, 16, 18, 19, 24]. This pathway is tightly regulated so that the host can efficiently initiate innate antiviral response and timely terminate it to avoid immune dysfunctions. Various post-translationally modifications, including different types of polyubiquitination, play critical roles in regulation of cGAS-MITA-mediated innate immune response. In this study, we identified USP44 as a positive regulator of innate immune response to DNA viruses by deubiquitinating and stabilizing MITA after viral infection.
Overexpression of USP44 increased cytosolic DNA- and DNA virus-triggered activation of downstream effector genes whereas knockdown of USP44 inhibited HSV-1-induced transcription of downstream effector genes in various cell types. Consistently, USP44-deficiency impaired HSV-1- and cytosolic DNA-induced transcription of downstream genes in murine immune cells. Furthermore, Usp44-/- mice showed lower serum cytokines levels, higher viral loads in lungs and brains after HSV-1 infection, and were more susceptible to HSV-1-induced death. In these experiments, USP44 did not affect innate immune response to the RNA viruses SeV, VSV or cytosolic dsRNA, suggesting that USP44 plays a specific role in modulating innate immune response to DNA viruses.
USP44 interacted with MITA following HSV-1 infection. Although previous studies have reported that USP44 is mainly localized in nucleus[38, 43], subcellular fractionation experiments showed that USP44 is distributed in both nucleus and cytoplasm. Interestingly, a portion of cytoplasmic USP44 migrated to membranes after viral infection. Given that MITA is a transmembrane protein and that the MITA-USP44 interaction was detected in the membraneous fraction after HSV-1 infection, a simple explanation is that USP44 interacts with MITA and is recruited to membranes following viral infection.
Several lines of evidence suggest that USP44 deconjugates K48-linked polyubiquitin from K236 of MITA after viral infection, which in turn inhibits proteasomal degradation of MITA. First, USP44 deubiquitinated MITA both in vitro and in vivo. Second, USP44 specifically removed K48- but not other linkage-mediated polyubiquitinaion of MITA. Third, USP44-deficiency increased HSV-1-induced K48-polyubiquitination and degradation of MITA, which was rescued by the proteasomal inhibitor MG132. Fourth, deubiquitination assays with MITA and its KR mutants showed that MITA(K236R) resisted USP44-mediated deubiquitination. Previous studies have reported that E3 ligases RNF5, TRIM30α and TRIM29 mediate K48-linked polyubiquitination of MITA at K150, K275, K288, K337 and K370 [33, 45–47], however, the E3 ligase responsible for MITA-ubiquitination at K236 remains to be identified.
Previously, it has been demonstrated that USP13 removes K27-linked polyubiquitin chains from MITA and impairs its recruitment of TBK1, contributing to inhibition of innate immune response to DNA viruses [36]. It has also been reported that USP20 deconjugates K33- and K48-linked polyubiquitin chains from MITA thus maintains its stability [48, 50]. Interestingly, USP20 has also been shown to deubiquitinate and stabilize ULK1 which is a negative regulator of MITA [51, 52]. Recently, it has been reported that CYLD removes K48-linked polyubiquitination from MITA at K150 [49]. However, CYLD-mediated deubiquitination lacks target specificity in the regulation of innate immune response as it has also been shown to deubiquitinate TRAF2, RIG-I and TBK1 [53–56]. Importantly, reconstitution experiments demonstrated that USP44-mediated regulation of MITA signaling is independent of USP20 and CYLD. In light of these and our studies, it is possible that MITA is distinctly regulated by different USPs in a spatial and temporal manner, so that it could be properly activated and inactivated at the onset and termination of innate immune response to DNA viruses.
Previous studies have shown that USP44 plays roles in tumorigenesis, cell cycle and DNA damage response [39, 40, 42, 43, 57]. It has also been shown that the DNA damage factors, meiotic recombination 11 homolog A (MRE11) and Ku70/80 complexes play important roles in initiation of dsDNA-induced type I IFN production [58, 59]. It would be interesting for the future studies to investigate whether USP44 is involved in the cross-talk between DNA damage and innate immune response.
Materials and methods
Reagents, antibodies, viruses and cells
Dual-specific luciferase assay kit (Promega); RNase inhibitor, lipofectamine 2000 (Thermo); GeneMute siRNA Transfection Reagent (SignaGen Laboratories); SYBR (Bio-Rad); polybrene (Millipore); 2’3’-cGAMP (InvivoGen); recombinant IFN-β (R&D Systems); HSV120, ISD (Sangon Biotech); and ELISA kits for murine IFN-β and IL-6 (BioLegend) and CXCL10 (Boster) were purchased from the indicated manufacturers.
Rabbit monoclonal antibodies against p-TBK1, p-IRF3, p-IKKβ, p-p65, MITA (Cell Signaling Technology); TBK1 (Abcam); β-actin (Abclonal); mouse monoclonal antibodies against Flag (Sigma); HA (OriGene); and ubiquitin (Santa Cruz Biotehcnology) were purchased for the indicated manufacturers.
HSV-1 (KOS strain) was purchased from China Center for Type Culture Collection. Human embryonic kidney (HEK293T) (Cat # CRL-11268) and human peripheral blood monocyte (THP-1) (Cat # TIB-202) cells were purchased from ATCC. Human foreskin fibroblasts (HFFs) were provided by Dr. Min-Hua Luo (Wuhan Institute of Virology).
Constructs
Expression plasmids for USP20-His, CYLD-His, USP44-His, USP20-Flag, CYLD-Flag, USP44-Flag, USP44-Myc and its mutant were constructed by standard molecular biology techniques. Expression plasmids for HA-tagged cGAS, MITA, TBK1, IRF3, ubiquitin and ubiquitin mutants, and Flag-tagged MITA, MITA mutants, and the IFNB promoter, ISRE and NF-κB reporter were previously described [60–63].
Transfection and reporter assays
HEK293T cells were transfected using a standard calcium phosphate precipitation protocol as previously described [64–66].
Stable cell lines
The HEK293T cells were transfected with two packaging plasmids (pGAG-Pol and pVSV-G) together with empty vector, or the indicated plasmids respectively by calcium phosphate precipitation. Twenty-four hours later, medium was replaced. Fourty-eight hours later, the recombinant virus-containing medium was then filtered with 0.45 μm filter and added to THP-1 or iMLF cells in the presence of polybrene (8 μg/mL). Twenty-four hours post infection, cells were selected with puromycin (1 μg/mL) for 7 days before experiments.
qPCR
Total RNA was isolated for qPCR analysis to measure mRNA levels of the indicated genes as previously described [63, 64, 67–69]. Data shown are the relative abundance of the indicated mRNA derived from human or mouse cells normalized to that of GAPDH. Primer sequences for qPCR assays are:
Human GAPDH: Forward-GACAAGCTTCCCGTTCTCAG;
Reverse-GAGTCAACGGATTTGGTGGT.
Human USP44: Forward-CGTATGTGACCAGTGTAA;
Reverse-GTGGCATATCATAAGTTGTT.
Human IFNB1: Forward-TTGTTGAGAACCTCCTGGCT;
Reverse-TGACTATGGTCCAGGCACAG.
Human IFIT1: Forward-TCATCAGGTCAAGGATAGTC;
Reverse-CCACACTGTATTTGGTGTCTACG.
Human IL6: Forward-GCCGCATCGCCGTCTCCTAC;
Reverse-CCTCAGCCCCCTCTGGGGTC.
Human CXCL10: Forward-GGTGAGAAGAGATGTCTGAATCC;
Reverse-GTCCATCCTTGGAAGCACTGCA.
Murine Gapdh: Forward-ACGGCCGCATCTTCTTGTGCA;
Reverse-ACGGCCAAATCCGTTCACACC.
Murine Usp44: Forward-CCACTTCCCAAAGGAGACTTAT;
Reverse-CACTGGTATCTCTCTGGAAACTC.
Murine Ifnb1: Forward-TCCTGCTGTGCTTCTCCACCACA;
Reverse-AAGTCCGCCCTGTAGGTGAGGTT.
Murine Ifit1: Forward-ACAGCAACCATGGGAGAGAATGCTG;
Reverse-ACGTAGGCCAGGAGGTTGTGCAT.
Murine Il6: Forward-TCTGCAAGAGACTTCCATCCAGTTGC;
Reverse-AGCCTCCGACTTGTGAAGTGGT.
Murine Cxcl10: Forward-ATCATCCCTGCGAGCCTATCCT;
Reverse-GACCTTTTTTGGCTAAACGCTTTC.
HSV-1 ICP22: Forward-TGTTTGGAGACCAGACGGTA;
Reverse-CATCGGAGATTTCATCATCG.
HSV-1 ICP27: Forward-GGCCTGATCGAAATCCTAGA;
Reverse-GTCAACTCGCAGACACGACT.
Co-immunoprecipitation and immunoblot analysis
HEK293T cells were lysed in 1mL NP-40 lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10 μg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). For each immunoprecipitation, 0.4 ml aliquot of the lysate was incubated with control IgG or the indicated antibody (0.5 μg) and 15 μL of Protein G Sepharose (GE Healthcare) at 4°C for 3 h or overnight. The Protein G sepharose beads were washed three times with 1 mL of lysis buffer containing 0.5 M NaCl. Immunoblot analysis was performed by standard procedures.
RNA interference
Double-stranded oligonucleotides corresponding to the targeting sequences were cloned into the pSuper-Retro-RNAi plasmid (Oligoengine) as previously described [70–72]. The following sequences were targeted for Human USP44-RNAi: #1 5’- GTAACAGGATTGAGAAATT-3’, #2 5’- GGAATTTCTTTGTGAACTT-3’; Human USP44-siRNA: 5’- GAATTGGAGTATCAAGTTA-3’. The siRNA was delivered into HFF cells by GeneMute siRNA Transfection Reagent (SignaGen Laboratories) according to the protocol provided by the manufacturer.
Preparations of BMDMs and MLFs
Bone marrow cells were isolated from tibia and femur. For preparation of bone marrow-derived macrophages (BMDMs), bone marrow cells were cultured in 10% M-CSF-containing conditional medium for 5 days. For murine lungs fibroblasts (MLFs), lungs were minced and digested in calcium and magnesium free HBSS containing 10 μg/ml type II collagenase and 20 μg/ml DNase I for 1 h at 37°C with shaking. Cell suspension was centrifuged at 500 g for 5 min. The cells were then plated in culture medium (1:1 [v/v] DMEM/Ham’s F-12 containing 10% fetal bovine serum (FBS), 50 U/ml penicillin, 50 μg/ml streptomycin, 15 mM HEPES, 2 mM L-glutamine). For generation of immortalized MLFs, MLFs were infected with SV40 in the presence of polybrene (8 μg/mL), 24 h later cells were cultured with fresh medium and immortalized cells were selected.
Usp44-/- mice
The genotype of the Usp44-/- mice was confirmed by sequencing PCR products amplified from the genomic DNA isolated from mouse tails using the following primers: #1: 5’- CTCCAATTCCGATCATATTCAATAAC-3’, #2: 5’-CCTCATCCCCACTTCCCAAAGGAG-3’ and #3: 5’-CTCTCTCCCCCATAAAGCCACTGC-3’.
HSV-1 infection of mice
Eight-week-old Usp44+/+ and Usp44-/- mice were intra-peritoneally (i.p.) or intra-nasally (i.n.) infected with HSV-1. The serum was collected at 6 h post infection for measurement of IFN-β, IL-6 and CXCL10 by ELISA. The viability of the infected mice was monitored for 9 days.
Plaque assay
The brain from HSV-1 infected mice were collected 5 days post infection. The brains were weighed and homogenized with PBS, followed by centrifugation at 1620 g for 30 min, and the supernatants were collected for plaque assays as previously described [60, 62, 67].
Subcellular fractionation
HEK293T cells were transfected with USP44-Flag for 24 h, nuclear and cytoplasmic fractions were extracted using NE-PER Nuclear and Cytoplasmic Extraction Reagents Kit (Thermo 78835).
For isolation of membraneous and cytosolic fractions, cells were washed with PBS and lysed by bouncing for 50 times in a homogenization buffer (10 mM Tris-HCl [PH 7.4], 10 mM potassium chloride, 2 mM magnesium chloride and 250 mM saccharose). The homogenate was centrifuged at 500 g for 10 min and the supernatant was centrifuged at 5000 g for 10 min. The supernatant from this step was further centrifuged at 20000 g for 30 min. The pellet was membraneous fraction and the supernatant was cytosol.
Deubiquitination assays
Cells were lysed with the lysis buffer (100 μl) and the supernatants were denatured at 95°C for 5 min in the presence of 1% SDS. The denatured lysates were diluted with NP-40 lysis buffer until the concentration of SDS was reduced < 0.1% followed by immunoprecipitation with the indicated antibodies.
In vitro deubiquitination assays
Denature-IP was performed to obtain ubiquitin-modified MITA from HEK293T cells co-transfected with Flag-tagged MITA and HA-Ubiquitin. The immunoprecipitates were eluted by Flag peptide (0.5 mg/ml, 60 μl). USP44 or USP44(C282A) protein was obtained utilizing an in vitro transcription and translation kit (Promega). The ubiquitin-modified Flag-MITA was incubated with USP44 or USP44(C282A) at 37°C for 2 h followed with overnight incubation at 16°C in the presence of ATP (1 μM). The mixtures were analyzed by immunoblots with the indicated antibodies.
Ethics statement
All mice were housed in the specific pathogen-free facility and viral infection experiments were carried out in an ABSL-2 facility at Wuhan Institute of Virology. The experimental protocol was adhered to the International Guiding Principles for Biomedical Involving Animals. The protocol for animal experiments were approved by the Institutional Animal Care and Use Committee of Wuhan Institute of Virology (approval number WIVA31201601).
Statistical analysis
Student’s t test was used for statistical analysis with Microsoft Excel and GraphPad Prism Software, P<0.05 was considered significant. For the mouse survival study, Kaplan-Meier survival curves were generated and analyzed by Log-Rank test.
Supporting information
S1 Fig [tif]
Identification of USP44 as a positive regulator of DNA virus-triggered signaling.
S2 Fig [tif]
Knockdown of USP44 inhibits cytosolic DNA-induced signaling.
S3 Fig [a]
USP44 is required for cytosolic DNA-triggered induction of antiviral genes.
S4 Fig [tif]
USP44 was detected in both the nuclear and cytoplasmic fractions.
S5 Fig [a]
USP44-mediated regulation of MITA is independent of USP20 or CYLD.
Zdroje
1. Tan X, Sun L, Chen J, Chen ZJ. Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids. Annual Review of Microbiology. 2018;72(1):447–78. doi: 10.1146/annurev-micro-102215-095605 30200854.
2. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449(7164):819–26. Epub 2007/10/19. doi: 10.1038/nature06246 17943118.
3. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–20. Epub 2010/03/23. doi: 10.1016/j.cell.2010.01.022 20303872.
4. Janeway CA Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216. Epub 2002/02/28. doi: 10.1146/annurev.immunol.20.083001.084359 11861602.
5. Akira S, Takeda K. Toll-like receptor signalling. Nature Reviews Immunology. 2004;4(7):499–511. doi: 10.1038/nri1391 15229469
6. Nakhaei P, Genin P, Civas A, Hiscott J. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin Immunol. 2009;21(4):215–22. Epub 2009/06/23. doi: 10.1016/j.smim.2009.05.001 19539500.
7. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–5. doi: 10.1038/nature04734 16625202
8. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003;198(3):513–20. Epub 2003/08/06. doi: 10.1084/jem.20030162 12900525; PubMed Central PMCID: PMC2194085.
9. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007;448(7152):501–5. Epub 2007/07/10. doi: 10.1038/nature06013 17618271.
10. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell. 2009;138(3):576–91. Epub 2009/07/28. doi: 10.1016/j.cell.2009.06.015 19631370; PubMed Central PMCID: PMC2747301.
11. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010;11(11):997–1004. Epub 2010/10/05. doi: 10.1038/ni.1932 20890285; PubMed Central PMCID: PMC3142795.
12. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol. 2011;12(10):959–65. Epub 2011/09/06. doi: 10.1038/ni.2091 21892174; PubMed Central PMCID: PMC3671854.
13. Li Y, Chen R, Zhou Q, Xu Z, Li C, Wang S, et al. LSm14A is a processing body-associated sensor of viral nucleic acids that initiates cellular antiviral response in the early phase of viral infection. Proceedings of the National Academy of Sciences. 2012;109(29):11770–5. doi: 10.1073/pnas.1203405109 22745163
14. Unterholzner L. The interferon response to intracellular DNA: why so many receptors? Immunobiology. 2013;218(11):1312–21. Epub 2013/08/22. doi: 10.1016/j.imbio.2013.07.007 23962476.
15. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway. Science. 2013;339(6121):786–91. doi: 10.1126/science.1232458 23258413
16. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, et al. Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA. Science. 2013;339(6121):826–30. doi: 10.1126/science.1229963 23258412
17. Civril F, Deimling T, de Oliveira Mann CC, Ablasser A, Moldt M, Witte G, et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature. 2013;498(7454):332–7. Epub 2013/06/01. doi: 10.1038/nature12305 23722159; PubMed Central PMCID: PMC3768140.
18. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity. 2008;29(4):538–50. Epub 2008/09/27. doi: 10.1016/j.immuni.2008.09.003 18818105.
19. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455(7213):674–8. doi: 10.1038/nature07317 18724357
20. Sun W, Li Y, Chen L, Chen H, You F, Zhou X, et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci U S A. 2009;106(21):8653–8. Epub 2009/05/13. doi: 10.1073/pnas.0900850106 19433799; PubMed Central PMCID: PMC2689030.
21. Jin L, Waterman PM, Jonscher KR, Short CM, Reisdorph NA, Cambier JC. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol Cell Biol. 2008;28(16):5014–26. Epub 2008/06/19. doi: 10.1128/MCB.00640-08 18559423; PubMed Central PMCID: PMC2519703.
22. Barber GN. STING-dependent signaling. Nature Immunology. 2011;12:929. doi: 10.1038/ni.2118 21934672
23. Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell. 2013;51(2):226–35. Epub 2013/06/12. doi: 10.1016/j.molcel.2013.05.022 23747010; PubMed Central PMCID: PMC3808999.
24. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461(7265):788–92. Epub 2009/09/25. doi: 10.1038/nature08476 19776740; PubMed Central PMCID: PMC4664154.
25. Dobbs N, Burnaevskiy N, Chen D, Gonugunta VK, Alto NM, Yan N. STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease. Cell Host Microbe. 2015;18(2):157–68. Epub 2015/08/04. doi: 10.1016/j.chom.2015.07.001 26235147; PubMed Central PMCID: PMC4537353.
26. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347(6227):aaa2630–aaa. doi: 10.1126/science.aaa2630 25636800
27. Tanaka Y, Chen ZJ. STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway. Science Signaling. 2012;5(214):ra20–ra. doi: 10.1126/scisignal.2002521 22394562
28. Hu M-M, Shu H-B. Cytoplasmic Mechanisms of Recognition and Defense of Microbial Nucleic Acids. Annual Review of Cell and Developmental Biology. 2018;34(1):357–79. doi: 10.1146/annurev-cellbio-100617-062903 30095291.
29. Hu MM, Yang Q, Xie XQ, Liao CY, Lin H, Liu TT, et al. Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus. Immunity. 2016;45(3):555–69. Epub 2016/09/18. doi: 10.1016/j.immuni.2016.08.014 27637147.
30. Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, Matsuura Y, et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity. 2010;33(5):765–76. Epub 2010/11/16. doi: 10.1016/j.immuni.2010.10.013 21074459.
31. Zhang J, Hu M-M, Wang Y-Y, Shu H-B. TRIM32 Protein Modulates Type I Interferon Induction and Cellular Antiviral Response by Targeting MITA/STING Protein for K63-linked Ubiquitination. Journal of Biological Chemistry. 2012;287(34):28646–55. doi: 10.1074/jbc.M112.362608 22745133
32. Wang Q, Liu X, Cui Y, Tang Y, Chen W, Li S, et al. The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity. 2014;41(6):919–33. Epub 2014/12/20. doi: 10.1016/j.immuni.2014.11.011 25526307.
33. Zhong B, Zhang L, Lei C, Li Y, Mao AP, Yang Y, et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity. 2009;30(3):397–407. Epub 2009/03/17. doi: 10.1016/j.immuni.2009.01.008 19285439.
34. Qin Y, Zhou MT, Hu MM, Hu YH, Zhang J, Guo L, et al. RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms. PLoS Pathog. 2014;10(9):e1004358. Epub 2014/09/26. doi: 10.1371/journal.ppat.1004358 25254379; PubMed Central PMCID: PMC4177927.
35. Chen M, Meng Q, Qin Y, Liang P, Tan P, He L, et al. TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses. Mol Cell. 2016;64(1):105–19. Epub 2016/09/27. doi: 10.1016/j.molcel.2016.08.025 27666593.
36. Sun H, Zhang Q, Jing YY, Zhang M, Wang HY, Cai Z, et al. USP13 negatively regulates antiviral responses by deubiquitinating STING. Nat Commun. 2017;8:15534. Epub 2017/05/24. doi: 10.1038/ncomms15534 28534493; PubMed Central PMCID: PMC5457515.
37. Ye L, Zhang Q, Liuyu T, Xu Z, Zhang MX, Luo MH, et al. USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA. PLoS Pathog. 2019;15(4):e1007680. Epub 2019/04/04. doi: 10.1371/journal.ppat.1007680 30943264; PubMed Central PMCID: PMC6464240.
38. Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10(8):550–63. Epub 2009/07/25. doi: 10.1038/nrm2731 19626045.
39. Stegmeier F, Rape M, Draviam VM, Nalepa G, Sowa ME, Ang XL, et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature. 2007;446(7138):876–81. Epub 2007/04/20. doi: 10.1038/nature05694 17443180.
40. Zhang Y, van Deursen J, Galardy PJ. Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia. PLoS One. 2011;6(8):e23389. Epub 2011/08/20. doi: 10.1371/journal.pone.0023389 PubMed Central PMCID: PMC3154946. 21853124
41. Fuchs G, Shema E, Vesterman R, Kotler E, Wolchinsky Z, Wilder S, et al. RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Mol Cell. 2012;46(5):662–73. Epub 2012/06/12. doi: 10.1016/j.molcel.2012.05.023 22681888; PubMed Central PMCID: PMC3374598.
42. Zhang Y, Foreman O, Wigle DA, Kosari F, Vasmatzis G, Salisbury JL, et al. USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. J Clin Invest. 2012;122(12):4362–74. Epub 2012/11/29. doi: 10.1172/JCI63084 23187126; PubMed Central PMCID: PMC3533537.
43. Mosbech A, Lukas C, Bekker-Jensen S, Mailand N. The Deubiquitylating Enzyme USP44 Counteracts the DNA Double-strand Break Response Mediated by the RNF8 and RNF168 Ubiquitin Ligases. Journal of Biological Chemistry. 2013;288(23):16579–87. doi: 10.1074/jbc.M113.459917 23615962
44. Lin YH, Forster M, Liang Y, Yu M, Wang H, Robert F, et al. USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model. Experimental Hematology. 2019. doi: 10.1016/j.exphem.2019.01.001 30639577
45. Wang Y, Lian Q, Yang B, Yan S, Zhou H, He L, et al. TRIM30alpha Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING. PLoS Pathog. 2015;11(6):e1005012. Epub 2015/06/27. doi: 10.1371/journal.ppat.1005012 26114947; PubMed Central PMCID: PMC4482643.
46. Li Q, Lin L, Tong Y, Liu Y, Mou J, Wang X, et al. TRIM29 negatively controls antiviral immune response through targeting STING for degradation. Cell Discov. 2018;4:13. Epub 2018/03/28. doi: 10.1038/s41421-018-0010-9 29581886; PubMed Central PMCID: PMC5859251.
47. Xing J, Zhang A, Zhang H, Wang J, Li XC, Zeng M-S, et al. TRIM29 promotes DNA virus infections by inhibiting innate immune response. Nature Communications. 2017;8(1). doi: 10.1038/s41467-017-00101-w 29038422
48. Zhang MX, Cai Z, Zhang M, Wang XM, Wang Y, Zhao F, et al. USP20 Promotes Cellular Antiviral Responses via Deconjugating K48-Linked Ubiquitination of MITA. J Immunol. 2019;202(8):2397–406. Epub 2019/03/01. doi: 10.4049/jimmunol.1801447 30814308.
49. Zhang L, Wei N, Cui Y, Hong Z, Liu X, Wang Q, et al. The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway. PLOS Pathogens. 2018;14(11):e1007435. doi: 10.1371/journal.ppat.1007435 30388174
50. Zhang M, Zhang M-X, Zhang Q, Zhu G-F, Yuan L, Zhang D-E, et al. USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA. Cell Research. 2016;26(12):1302–19. doi: 10.1038/cr.2016.125 27801882
51. Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155(3):688–98. Epub 2013/10/15. doi: 10.1016/j.cell.2013.09.049 24119841; PubMed Central PMCID: PMC3881181.
52. Kim JH, Seo D, Kim SJ, Choi DW, Park JS, Ha J, et al. The deubiquitinating enzyme USP20 stabilizes ULK1 and promotes autophagy initiation. EMBO Rep. 2018;19(4). Epub 2018/03/01. doi: 10.15252/embr.201744378 29487085; PubMed Central PMCID: PMC5891421.
53. Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature. 2003;424(6950):801–5. doi: 10.1038/nature01802 12917691
54. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature. 2003;424(6950):793–6. doi: 10.1038/nature01803 12917689
55. Zhang M, Wu X, Lee AJ, Jin W, Chang M, Wright A, et al. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem. 2008;283(27):18621–6. Epub 2008/05/10. doi: 10.1074/jbc.M801451200 18467330; PubMed Central PMCID: PMC2441564.
56. Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS, et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 2008;9(9):930–6. Epub 2008/07/19. doi: 10.1038/embor.2008.136 18636086; PubMed Central PMCID: PMC2529351.
57. Holland AJ, Cleveland DW. The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregation. J Clin Invest. 2012;122(12):4325–8. Epub 2012/11/29. doi: 10.1172/JCI66420 23187131; PubMed Central PMCID: PMC3533566.
58. Kondo T, Kobayashi J, Saitoh T, Maruyama K, Ishii KJ, Barber GN, et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A. 2013;110(8):2969–74. Epub 2013/02/08. doi: 10.1073/pnas.1222694110 23388631; PubMed Central PMCID: PMC3581880.
59. Li Y, Wu Y, Zheng X, Cong J, Liu Y, Li J, et al. Cytoplasm-Translocated Ku70/80 Complex Sensing of HBV DNA Induces Hepatitis-Associated Chemokine Secretion. Front Immunol. 2016;7:569. Epub 2016/12/21. doi: 10.3389/fimmu.2016.00569 27994596; PubMed Central PMCID: PMC5136554.
60. Lian H, Wei J, Zang R, Ye W, Yang Q, Zhang X-N, et al. ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response. Nature Communications. 2018;9(1). doi: 10.1038/s41467-018-05559-w 30135424
61. Luo WW, Li S, Li C, Lian H, Yang Q, Zhong B, et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING. Nat Immunol. 2016;17(9):1057–66. Epub 2016/07/19. doi: 10.1038/ni.3510 27428826.
62. Wei J, Lian H, Guo W, Chen YD, Zhang XN, Zang R, et al. SNX8 modulates innate immune response to DNA virus by mediating trafficking and activation of MITA. PLoS Pathog. 2018;14(10):e1007336. Epub 2018/10/16. doi: 10.1371/journal.ppat.1007336 30321235; PubMed Central PMCID: PMC6188873.
63. Luo WW, Li S, Li C, Zheng ZQ, Cao P, Tong Z, et al. iRhom2 is essential for innate immunity to RNA virus by antagonizing ER- and mitochondria-associated degradation of VISA. PLoS Pathog. 2017;13(11):e1006693. Epub 2017/11/21. doi: 10.1371/journal.ppat.1006693 29155878; PubMed Central PMCID: PMC5722342.
64. Yang Q, Liu TT, Lin H, Zhang M, Wei J, Luo WW, et al. TRIM32-TAX1BP1-dependent selective autophagic degradation of TRIF negatively regulates TLR3/4-mediated innate immune responses. PLoS Pathog. 2017;13(9):e1006600. Epub 2017/09/13. doi: 10.1371/journal.ppat.1006600 28898289; PubMed Central PMCID: PMC5595311.
65. Fu YZ, Guo Y, Zou HM, Su S, Wang SY, Yang Q, et al. Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response. PLoS Pathog. 2019;15(5):e1007691. Epub 2019/05/21. doi: 10.1371/journal.ppat.1007691 31107917.
66. Nie Y, Ran Y, Zhang H-Y, Huang Z-F, Pan Z-Y, Wang S-Y, et al. GPATCH3 negatively regulates RLR-mediated innate antiviral responses by disrupting the assembly of VISA signalosome. PLOS Pathogens. 2017;13(4):e1006328. doi: 10.1371/journal.ppat.1006328 28414768
67. Zhou Q, Lin H, Wang S, Wang S, Ran Y, Liu Y, et al. The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling. Cell Host Microbe. 2014;16(4):450–61. Epub 2014/10/10. doi: 10.1016/j.chom.2014.09.006 25299331.
68. Yang Y, Wang SY, Huang ZF, Zou HM, Yan BR, Luo WW, et al. The RNA-binding protein Mex3B is a coreceptor of Toll-like receptor 3 in innate antiviral response. Cell Res. 2016;26(3):288–303. Epub 2016/01/30. doi: 10.1038/cr.2016.16 26823206; PubMed Central PMCID: PMC4783467.
69. Zhang Y, Lei CQ, Hu YH, Xia T, Li M, Zhong B, et al. Kruppel-like factor 6 is a co-activator of NF-kappaB that mediates p65-dependent transcription of selected downstream genes. J Biol Chem. 2014;289(18):12876–85. Epub 2014/03/19. doi: 10.1074/jbc.M113.535831 24634218; PubMed Central PMCID: PMC4007475.
70. Hu MM, Liao CY, Yang Q, Xie XQ, Shu HB. Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5. J Exp Med. 2017;214(4):973–89. Epub 2017/03/03. doi: 10.1084/jem.20161015 28250012; PubMed Central PMCID: PMC5379974.
71. Huang ZF, Zou HM, Liao BW, Zhang HY, Yang Y, Fu YZ, et al. Human Cytomegalovirus Protein UL31 Inhibits DNA Sensing of cGAS to Mediate Immune Evasion. Cell Host Microbe. 2018;24(1):69–80 e4. Epub 2018/06/26. doi: 10.1016/j.chom.2018.05.007 29937271.
72. Xu ZS, Zhang HX, Zhang YL, Liu TT, Ran Y, Chen LT, et al. PASD1 promotes STAT3 activity and tumor growth by inhibiting TC45-mediated dephosphorylation of STAT3 in the nucleus. J Mol Cell Biol. 2016;8(3):221–31. Epub 2016/02/20. doi: 10.1093/jmcb/mjw005 26892021.
Článek vyšel v časopise
PLOS Pathogens
2020 Číslo 1
- Může hubnutí souviset s vyšším rizikem nádorových onemocnění?
- Polibek, který mi „vzal nohy“ aneb vzácný výskyt EBV u 70leté ženy – kazuistika
- Zkoušku z bariatrické chirurgie nejlépe složil ChatGPT-4. Za ním zůstaly Bing a Bard
- Raději si zajděte na oční! Jak souvisí citlivost zraku s rozvojem demence?
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
Nejčtenější v tomto čísle
- Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells
- Hydropic anthelmintics against parasitic nematodes
- Norovirus infection results in eIF2α independent host translation shut-off and remodels the G3BP1 interactome evading stress granule formation
- Modular Mimicry and Engagement of the Hippo Pathway by Marburg Virus VP40: Implications for Filovirus Biology and Budding